Drägerwerk AG & Co. KGaA (DRWKF) on Thursday announced preliminary figures showing performance in fiscal 2025, with net sales rising 5.3 percent year over year on a currency-adjusted basis to around euros 3.48 billion, exceeding the company's latest forecast.
Growth was supported by a strong year-end, with the medical division increasing net sales 7.4 percent to about euros 2.0 billion, while the safety division grew 2.5 percent to roughly euros 1.49 billion.
EBIT rose sharply to an estimated euros 226 million to euros 236 million, lifting the EBIT margin to around 6.5 to 6.8 percent. Order intake also strengthened to approximately euros 3.58 billion.
For 2026, Dräger expects continued sales growth and an EBIT margin of 5.0 to 7.5 percent.
DRWKF is currently trading at $81.00 on the OTC Markets.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.